• enterprise value to revenue forward of cellectis s.a. – euronext:alcls TradingView Sun, 05 Jul 2026 14:09:24 GMT
• Price to book forward of Cellectis S.A. – EURONEXT:ALCLS TradingView Sun, 05 Jul 2026 09:05:21 GMT
• Cellectis monthly capital update shows 100.7M shares, 105.6M votes Stock Titan Thu, 02 Jul 2026 20:30:00 GMT
• Monthly information on share capital and company voting rights Yahoo Finance Thu, 02 Jul 2026 20:30:00 GMT
• cellectis s.a. sponsored adr financial disclosures & sec filings TradingView Wed, 01 Jul 2026 21:12:41 GMT
• price to sales forward of cellectis s.a. – euronext:alcls TradingView Tue, 30 Jun 2026 18:04:24 GMT
• price to earnings forward of cellectis s.a. – euronext:alcls TradingView Tue, 30 Jun 2026 11:48:41 GMT
• enterprise value to ebitda forward of cellectis s.a. – fwb:zva TradingView Tue, 30 Jun 2026 05:31:39 GMT
• cellectis s.a. sponsored adr actuals & estimates (nasdaq:clls) TradingView Fri, 26 Jun 2026 11:26:25 GMT
• Shareholders of Cellectis (NASDAQ: CLLS) reject savings plan issue Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Cellectis Shareholders Approve 2025 Accounts and Expand Capital-Raising Powers at June 25 Meeting TipRanks Thu, 25 Jun 2026 21:30:41 GMT
• Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026 Caledonian Record Thu, 25 Jun 2026 20:30:50 GMT
• [6-K] Cellectis S.A. Current Report (Foreign Issuer) | CLLS SEC Filing - Form 6-K Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Press Release: Cellectis Reports Results From Shareholders Meeting Held on June 25, 2026 Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• Cellectis (CLLS) meeting backs capital issuance mandates but rejects employee savings share plan Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Cellectis Shareholders Approve Board-Backed Resolutions at June 25, 2026 Meeting TipRanks Thu, 25 Jun 2026 07:00:00 GMT
• cellectis shareholders back 29 motions, reject one at june 25 meeting Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• shareholders of cellectis (nasdaq: clls) reject savings plan issue Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• cellectis sa (clls) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• cellectis sa (clls) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• cellectis sa (clls) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 01:07:49 GMT
• cellectis sa (clls) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 01:07:13 GMT
• cellectis sa (clls) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 00:57:56 GMT
• cellectis sa (clls) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 00:57:48 GMT
• cellectis sa (clls) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 23:20:45 GMT
• cellectis sa (clls) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 19:29:44 GMT
• cellectis sa (clls) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 19:17:12 GMT
• cellectis sa (clls) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 18:53:29 GMT
• cellectis sa (clls) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cellectis sa (clls) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cellectis sa (clls) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cellectis wins fda rmat status for leukemia car-t candidate lasme-cel; shares rise MSN Sat, 13 Jun 2026 02:15:04 GMT
• cellectis wins fda rmat status for leukemia car-t candidate lasme-cel; shares rise MSN Fri, 12 Jun 2026 06:15:15 GMT
• cellectis reports strong car-t cancer trial data at eha 2026 grafa.com Thu, 11 Jun 2026 12:31:00 GMT
• le journal des biotechs : andré choulika, pdg de cellectis marvel's wolverine 2026 release (ho4zt1unbz) Fathom Journal Thu, 11 Jun 2026 09:06:00 GMT
• cellectis wins fda rmat status for leukemia car-t candidate lasme-cel; shares rise MSN Thu, 11 Jun 2026 08:53:50 GMT
• cellectis presents final phase 1 results of lasme-cel and preliminary results on eti-cel at eha 2026 congress GlobeNewswire Thu, 11 Jun 2026 07:00:00 GMT
• cellectis: 100% response rate for lasmé-cel at eha 2026, but with only 7 patients Idéal Investisseur Thu, 11 Jun 2026 07:00:00 GMT
• cellectis car-t trials show responses in heavily pretreated blood cancers Stock Titan Thu, 11 Jun 2026 06:42:05 GMT
• cellectis (clls) receives fda rmat designation for car-t therapy, shares rise GuruFocus Wed, 10 Jun 2026 07:40:43 GMT
• Cellectis CAR-T trials show responses in heavily pretreated blood cancers Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• Cellectis Stock Surges Nearly 9% Following Key FDA Approval Idéal Investisseur Wed, 10 Jun 2026 07:00:00 GMT
• Cellectis stock rises on FDA therapy designation By Investing.com Investing.com UK Wed, 10 Jun 2026 07:00:00 GMT
• CLLS Stock Rallies Over 24% After Hours — Here's Why Asianet Newsable Wed, 10 Jun 2026 07:00:00 GMT
• cellectis presents final phase 1 results of lasme-cel and preliminary results on eti-cel at eha 2026 congress Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• cellectis: fda grants rmat status to lasmé-cel for b-cell all leukemia Idéal Investisseur Wed, 10 Jun 2026 07:00:00 GMT
• cellectis wins fda rmat status for leukemia car-t candidate lasme-cel; shares rise MSN Wed, 10 Jun 2026 05:11:48 GMT
• cellectis (clls) achieves rmat designation for car-t therapy GuruFocus Wed, 10 Jun 2026 00:14:15 GMT
• Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r... Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• FDA grants RMAT status to Cellectis off-the-shelf leukemia CAR-T Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• Cellectis (CLLS) Achieves RMAT Designation for CAR-T Therapy GuruFocus Tue, 09 Jun 2026 07:00:00 GMT
• Cellectis (CLLS) Receives FDA RMAT Designation for CAR-T Therapy, Shares Rise GuruFocus Tue, 09 Jun 2026 07:00:00 GMT
• fda grants rmat to cellectis (nasdaq: clls) allogeneic car-t for r/r b-all Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• cellectis says us fda granted rmat designation to lasme-cel to treat r/r b-all patients marketscreener.com Tue, 09 Jun 2026 07:00:00 GMT
• Cellectis now has 100,691,658 shares and 106,134,467 voting rights Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• monthly information on share capital and company voting rights Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• cellectis shares dip ahead of june data investors wait for Bez Kabli Mon, 01 Jun 2026 07:00:00 GMT
• barclays maintains cellectis(clls.us) with buy rating, raises target price to $9 Moomoo Fri, 29 May 2026 23:52:35 GMT
• Cellectis (CLLS) Slides 3% as Biotech Faces Resistance Near $3.70 - Risk Reward Setups dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• cellectis s a : report of the board of directors - combined general meeting of shareholders - june 25, 2026 marketscreener.com Fri, 29 May 2026 07:00:00 GMT
• clls stock price, quote & chart | cellectis - adr (nasdaq:clls) ChartMill Fri, 29 May 2026 07:00:00 GMT
• barclays maintains cellectis(clls.us) with buy rating, raises target price to $9 富途牛牛 Thu, 28 May 2026 09:34:00 GMT
• barclays initiates cellectis stock with overweight, $9 target by investing.com Investing.com UK Thu, 28 May 2026 07:00:00 GMT
• clls initiated coverage by barclays -- rating set to overweight GuruFocus Thu, 28 May 2026 07:00:00 GMT
• barclays initiates coverage of cellectis sa - depositary receipt (clls) with overweight recommendation MSN Thu, 28 May 2026 07:00:00 GMT
• CLLS Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares - Non-GAAP Earnings dars.gov.et Tue, 26 May 2026 07:00:00 GMT
• CLLS Q1 2026 Earnings: Narrower-Than-Expected Loss as Gene-Editing Pipeline Advances - Weak Earnings Momentum dars.gov.et Sat, 23 May 2026 07:00:00 GMT
• Cellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers The Globe and Mail Fri, 22 May 2026 07:00:00 GMT
• cellectis’s swot analysis: biotech stock shows promise in car-t therapy Investing.com Fri, 22 May 2026 07:00:00 GMT
• cellectis sa (stu:zva) stock price & 30 year financial data GuruFocus Thu, 21 May 2026 21:10:41 GMT
• alcls: lead allogeneic car-t therapies show strong efficacy and commercial potential TradingView Thu, 21 May 2026 13:20:30 GMT
• cellectis calls june 25, 2026 shareholders’ meeting to approve 2025 results and broad capital-issuance powers TipRanks Thu, 21 May 2026 10:35:54 GMT
• cellectis sets june 25, 2026 date for annual shareholders meeting in paris The Globe and Mail Thu, 21 May 2026 07:00:00 GMT
• cellectis' annual shareholders general meeting to be held on june 25, 2026 marketscreener.com Thu, 21 May 2026 07:00:00 GMT
• cellectis sets june 25, 2026 date for annual shareholders meeting in paris TipRanks Wed, 20 May 2026 23:21:54 GMT
• cellectis s a : notice of meeting - combined general meeting of shareholders - june 25, 2026 marketscreener.com Wed, 20 May 2026 20:48:10 GMT
• cellectis’ annual shareholders general meeting to be held on june 25, 2026 Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• gene-editing biotech cellectis plans june 25 shareholder meeting in paris Stock Titan Wed, 20 May 2026 07:00:00 GMT
• cellectis (nasdaq: clls) schedules june 25, 2026 annual meeting in paris Stock Titan Wed, 20 May 2026 07:00:00 GMT
• cellectis (clls) faces 2025 loss, seeks wide capital-raising mandates at june meeting Stock Titan Wed, 20 May 2026 07:00:00 GMT
• clls stock price, quote & chart | cellectis - adr (nasdaq:clls) ChartMill Tue, 19 May 2026 07:00:00 GMT
• how cellectis clls prepares for market disruptions q4 2025 eps beats forecasts - ebitda margin trends Newser Sun, 17 May 2026 07:00:00 GMT
• cellectis s.a. (epa:alcls) just reported first-quarter earnings and analysts are lifting their estimates simplywall.st Thu, 14 May 2026 07:00:00 GMT
• alcls.pa stock price, quote & chart | cellectis (epa:alcls) ChartMill Wed, 13 May 2026 07:00:00 GMT
• cellectis (clls) announces clinical trial presentations at eha c GuruFocus Wed, 13 May 2026 01:34:55 GMT
• cellectis to present clinical data on lasme-cel, eti-cel at eha congress TipRanks Tue, 12 May 2026 19:38:55 GMT
• cellectis to unveil key lasme-cel and eti-cel data at eha 2026 TipRanks Tue, 12 May 2026 14:27:52 GMT
• cellectis (nasdaq: clls) highlights lasme-cel and eti-cel data for eha 2026 Stock Titan Tue, 12 May 2026 13:35:06 GMT
• Cellectis to Present Allogeneic CAR-T Data at EHA Congress in June 2026 Idéal Investisseur Tue, 12 May 2026 07:00:00 GMT
• cellectis to present clinical data on lasme-cel and eti-cel at eha 2026 annual congress Yahoo Finance Tue, 12 May 2026 07:00:00 GMT
• cellectis leukemia, lymphoma cell therapies hit eha 2026 stage Stock Titan Tue, 12 May 2026 07:00:00 GMT
• cellectis (clls) announces clinical trial presentations at eha c GuruFocus Tue, 12 May 2026 07:00:00 GMT
• cellectis: stable net loss of $17.8m in q1, cash secured until 2027 Idéal Investisseur Tue, 12 May 2026 07:00:00 GMT
• cellectis (clls) reports q1 revenue and highlights future develo GuruFocus Tue, 12 May 2026 03:22:30 GMT
• cellectis (clls) reports strong cash position for future operati GuruFocus Tue, 12 May 2026 02:04:24 GMT
• cellectis reports q1 adjusted eps (16c) vs. (17c) last year TipRanks Tue, 12 May 2026 00:56:09 GMT
• press release: cellectis reports financial results for the first quarter 2026 Moomoo Mon, 11 May 2026 20:30:00 GMT
• cellectis s.a. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 20:30:00 GMT
• Cellectis Reports Financial Results for the First Quarter 2026 Stock Titan Mon, 11 May 2026 07:00:00 GMT
• Cellectis (CLLS) Reports Strong Cash Position for Future Operati GuruFocus Mon, 11 May 2026 07:00:00 GMT
• cellectis (clls) q1 2026: $7.5m revenue, higher r&d spend and cash runway Stock Titan Mon, 11 May 2026 07:00:00 GMT
• cellectis sa reports results for the quarter ended march 31 - earnings summary TradingView Mon, 11 May 2026 07:00:00 GMT
• cellectis (clls) reports q1 revenue and highlights future develo GuruFocus Mon, 11 May 2026 07:00:00 GMT
• cellectis q1 2026 results highlight car-t pipeline milestones, new epigenetic platform and licensing dispute TipRanks Mon, 11 May 2026 07:00:00 GMT
• cellectis reports q1 adjusted eps (16c) vs. (17c) last year TipRanks Mon, 11 May 2026 07:00:00 GMT
• earnings preview: cellectis to report financial results post-market on may 11 Moomoo Fri, 08 May 2026 07:00:00 GMT
• cellectis sa expected to post a loss of 26 cents a share - earnings preview TradingView Fri, 08 May 2026 07:00:00 GMT
• monthly information on share capital and company voting rights Taiwan News Thu, 07 May 2026 07:00:00 GMT
• monthly information on share capital and company voting rights Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• as of april 30, cellectis had 100.6m shares and 106.0m votes Stock Titan Wed, 06 May 2026 07:00:00 GMT
• cellectis to report first quarter financial results on may 11, 2026 The Manila Times Tue, 05 May 2026 07:00:00 GMT
• No call planned as Cellectis sets May 11 release for Q1 results Stock Titan Mon, 04 May 2026 07:00:00 GMT
• cellectis to report first quarter financial results on may 11, 2026 GlobeNewswire Mon, 04 May 2026 07:00:00 GMT
Cellectis S.A(NASDAQ:CLLS) 
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an all...
Website: http://www.cellectis.com
Founded: 1999
Full Time Employees: 253
Sector: Healthcare
Industry: Biotechnology